Xellar Biosystems is an AI biotechnology company that provides drug discovery and development solutions. It offers an organ chip culture system to replicate the multi-cellular environment of human organs in a controllable laboratory setting, the Preclinical Development Platform enables the creation of tissue and organ chip disease models, imaging tool to analysis of cellular and tissue-level responses within our organ-on-chip models, etc.